이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Cosmecca Korea 미래 성장

Future 기준 확인 4/6

Cosmecca Korea (는) 각각 연간 25.6% 및 14% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 25.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 20.1% 로 예상됩니다.

주요 정보

21.6%

수익 성장률

22.5%

EPS 성장률

Personal Products 수익 성장	13.8%
매출 성장률	14.8%
향후 자기자본 수익률	20.8%
애널리스트 커버리지	Good
마지막 업데이트	19 Sep 2024

최근 미래 성장 업데이트

Recent updates

Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 73% Above Its Share Price

Aug 29

Is Now The Time To Look At Buying Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?

Aug 07

Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Looks Just Right With A 54% Price Jump

Jun 24

With EPS Growth And More, Cosmecca Korea (KOSDAQ:241710) Makes An Interesting Case

Jun 16

Market Participants Recognise Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Revenues Pushing Shares 29% Higher

May 10

Is Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Trading At A 44% Discount?

Apr 19

Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless

Mar 25

We Like These Underlying Return On Capital Trends At Cosmecca Korea (KOSDAQ:241710)

Mar 01

Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 37% Above Its Share Price

Mar 23

Cosmecca Korea (KOSDAQ:241710) Share Prices Have Dropped 53% In The Last Three Years

Mar 04

When Should You Buy Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?

Feb 17

The Returns At Cosmecca Korea (KOSDAQ:241710) Provide Us With Signs Of What's To Come

Feb 02

Should You Use Cosmecca Korea's (KOSDAQ:241710) Statutory Earnings To Analyse It?

Jan 18

Is Cosmecca Korea (KOSDAQ:241710) Using Too Much Debt?

Jan 04

What You Need To Know About Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Investor Composition

Dec 23

Are Investors Undervaluing Cosmecca Korea Co., Ltd. (KOSDAQ:241710) By 32%?

Dec 08

Cosmecca Korea's (KOSDAQ:241710) Stock Price Has Reduced 58% In The Past Three Years

Nov 25

수익 및 매출 성장 예측

KOSDAQ:A241710 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (KRW Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	742,129	60,240	57,295	77,356	6
12/31/2025	646,425	48,817	44,250	61,510	8
12/31/2024	570,226	41,300	28,153	43,815	5
6/30/2024	508,494	34,448	7,843	42,726	N/A
3/31/2024	480,375	26,635	7,706	32,582	N/A
12/31/2023	470,719	22,319	23,246	41,969	N/A
9/30/2023	454,429	17,991	33,974	50,052	N/A
6/30/2023	441,574	11,346	30,045	44,224	N/A
3/31/2023	426,334	7,151	25,430	38,063	N/A
12/31/2022	399,399	2,656	4,911	16,695	N/A
9/30/2022	386,671	3,584	481	8,358	N/A
6/30/2022	380,431	6,114	-961	6,684	N/A
3/31/2022	391,991	6,919	519	8,499	N/A
12/31/2021	396,466	8,904	-1,294	7,888	N/A
9/30/2021	383,994	7,478	-11,022	372	N/A
6/30/2021	364,225	3,676	4,356	15,544	N/A
3/31/2021	343,194	2,459	-5,861	8,796	N/A
12/31/2020	339,056	2,622	-3,035	11,910	N/A
9/30/2020	341,779	1,850	-3,482	14,849	N/A
6/30/2020	342,620	3,097	-12,069	9,080	N/A
3/31/2020	351,242	5,818	-9,302	14,857	N/A
12/31/2019	347,018	4,866	-11,607	19,353	N/A
9/30/2019	338,290	2,715	-12,430	24,402	N/A
6/30/2019	355,203	4,106	-40,557	8,414	N/A
3/31/2019	335,242	8,090	-27,271	17,598	N/A
12/31/2018	303,293	8,972	-32,228	10,837	N/A
9/30/2018	272,601	12,943	-34,658	6,496	N/A
6/30/2018	214,660	11,601	-10,114	16,409	N/A
3/31/2018	184,919	8,488	N/A	5,796	N/A
12/31/2017	182,328	9,934	N/A	10,441	N/A
9/30/2017	182,438	11,919	N/A	11,074	N/A
6/30/2017	187,953	13,176	N/A	2,568	N/A
3/31/2017	181,618	12,240	N/A	6,973	N/A
12/31/2016	165,176	11,505	N/A	4,401	N/A
9/30/2016	147,204	9,708	N/A	4,281	N/A
6/30/2016	131,028	8,865	N/A	9,353	N/A
3/31/2016	110,391	6,347	N/A	2,698	N/A
12/31/2015	99,150	5,027	N/A	2,703	N/A
12/31/2014	68,318	1,355	N/A	4,651	N/A

애널리스트 미래 성장 예측

수입 대 저축률: A241710 의 연간 예상 수익 증가율( 25.6% )이 saving rate( 2.6% 보다 높습니다. ).

수익 vs 시장: A241710 의 연간 수익( 25.6% ) KR 시장( 28.4% 보다 느리게 성장할 것으로 예상됩니다. 28.4% 연간).

고성장 수익: A241710 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: A241710 의 수익(연간 14% ) KR 시장( 10.7% 보다 빠르게 성장할 것으로 예상됩니다. 10.7% 연간).

고성장 수익: A241710 의 수익(연간 14% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: A241710 의 자본 수익률은 3년 내에 최고 수준이 될 것으로 예상됩니다. ( 20.1 %)

Cosmecca Korea 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Price target increased by 11% to ₩93,250

Consensus EPS estimates increase by 14%

Price target increased by 17% to ₩68,667

Consensus EPS estimates increase by 14%

Consensus EPS estimates fall by 14%

Consensus EPS estimates increase by 26%, revenue downgraded

Recent updates

Price target increased by 11% to ₩93,250

Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 73% Above Its Share Price

Consensus EPS estimates increase by 14%

Is Now The Time To Look At Buying Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?

Investor sentiment deteriorates as stock falls 18%

Now 39% overvalued after recent price rise

Now 22% overvalued after recent price rise

Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Looks Just Right With A 54% Price Jump

Investor sentiment improves as stock rises 16%

Price target increased by 17% to ₩68,667

With EPS Growth And More, Cosmecca Korea (KOSDAQ:241710) Makes An Interesting Case

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 14%

Market Participants Recognise Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Revenues Pushing Shares 29% Higher

Investor sentiment improves as stock rises 20%

New minor risk - Share price stability

Is Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Trading At A 44% Discount?

Investor sentiment improves as stock rises 22%

Cosmecca Korea Co., Ltd. (KOSDAQ:241710) Shares Slammed 27% But Getting In Cheap Might Be Difficult Regardless

Now 21% undervalued after recent price drop

We Like These Underlying Return On Capital Trends At Cosmecca Korea (KOSDAQ:241710)

Consensus EPS estimates fall by 14%

Investor sentiment improves as stock rises 19%

Consensus EPS estimates increase by 26%, revenue downgraded

Investor sentiment improves as stock rises 26%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

New major risk - Revenue and earnings growth

Investor sentiment improves as stock rises 15%

Investor sentiment improves as stock rises 19%

Investor sentiment improves as stock rises 35%

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Price target decreased to ₩11,000

No independent directors

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Price target decreased to ₩16,500

Consensus EPS estimates fall by 63%

Price target decreased to ₩17,000

Investor sentiment deteriorated over the past week

Price target increased to ₩19,250

No independent directors

Consensus forecasts updated

Price target increased to ₩17,667

Consensus forecasts updated

Price target increased to ₩17,000

Investor sentiment improved over the past week

Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Intrinsic Value Is Potentially 37% Above Its Share Price

Cosmecca Korea (KOSDAQ:241710) Share Prices Have Dropped 53% In The Last Three Years

Price target raised to ₩15,333

When Should You Buy Cosmecca Korea Co., Ltd. (KOSDAQ:241710)?

New 90-day high: ₩14,550

The Returns At Cosmecca Korea (KOSDAQ:241710) Provide Us With Signs Of What's To Come

New 90-day high: ₩13,750

Should You Use Cosmecca Korea's (KOSDAQ:241710) Statutory Earnings To Analyse It?

Is Cosmecca Korea (KOSDAQ:241710) Using Too Much Debt?

What You Need To Know About Cosmecca Korea Co., Ltd.'s (KOSDAQ:241710) Investor Composition

Are Investors Undervaluing Cosmecca Korea Co., Ltd. (KOSDAQ:241710) By 32%?

Cosmecca Korea's (KOSDAQ:241710) Stock Price Has Reduced 58% In The Past Three Years

Analysts lower EPS estimates to ₩332

Analysts lower EPS estimates to ₩465

New 90-day high - ₩14,550

New 90-day high - ₩13,750

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측